Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Expanded access is no longer available for this treatment.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: June 29, 2007
Last updated: May 30, 2013
Last verified: May 2013